Swiss All Share Index
15.591,90
PKT
-150,35
PKT
-0,96
%
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.11.21 | UBS Neutral | JP Morgan Chase & Co. | |
| 04.11.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.11.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 04.11.21 | Roche Neutral | UBS AG | |
| 04.11.21 | Nestlé Hold | Jefferies & Company Inc. | |
| 03.11.21 | ams-OSRAM Buy | Hauck & Aufhäuser Privatbankiers KGaA | |
| 03.11.21 | ams-OSRAM Hold | Deutsche Bank AG | |
| 03.11.21 | ams-OSRAM Underweight | Barclays Capital | |
| 03.11.21 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 02.11.21 | Holcim Buy | Deutsche Bank AG | |
| 02.11.21 | Clariant Underweight | JP Morgan Chase & Co. | |
| 02.11.21 | ams-OSRAM Underweight | Barclays Capital | |
| 02.11.21 | ams-OSRAM Overweight | JP Morgan Chase & Co. | |
| 01.11.21 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.11.21 | Holcim Buy | UBS AG | |
| 01.11.21 | UBS Outperform | RBC Capital Markets | |
| 01.11.21 | Holcim Outperform | Credit Suisse Group | |
| 01.11.21 | Holcim Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.11.21 | Clariant Neutral | Goldman Sachs Group Inc. | |
| 29.10.21 | Holcim Neutral | JP Morgan Chase & Co. | |
| 29.10.21 | Clariant Hold | Jefferies & Company Inc. | |
| 29.10.21 | Clariant Neutral | UBS AG | |
| 29.10.21 | Swiss Re Sell | UBS AG | |
| 29.10.21 | Clariant Buy | Baader Bank | |
| 29.10.21 | Swiss Re Hold | Jefferies & Company Inc. | |
| 28.10.21 | Clariant Equal-weight | Morgan Stanley | |
| 28.10.21 | Holcim Buy | Deutsche Bank AG | |
| 28.10.21 | Clariant Underweight | JP Morgan Chase & Co. | |
| 28.10.21 | Clariant Buy | Kepler Cheuvreux | |
| 28.10.21 | UBS Buy | Jefferies & Company Inc. | |
| 28.10.21 | Clariant Neutral | Goldman Sachs Group Inc. | |
| 27.10.21 | UBS Equal-weight | Morgan Stanley | |
| 27.10.21 | UBS Outperform | RBC Capital Markets | |
| 27.10.21 | Novartis Underweight | Barclays Capital | |
| 27.10.21 | UBS Underweight | Barclays Capital | |
| 27.10.21 | Novartis Sell | Deutsche Bank AG | |
| 27.10.21 | UBS Buy | Deutsche Bank AG | |
| 27.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.10.21 | UBS Outperform | Credit Suisse Group | |
| 27.10.21 | Novartis Neutral | Credit Suisse Group |